HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

streptokinase-plasminogen complex

activates plasminogen to plasmin

Also Known As:

strep-plas complex

Networked: 7 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.	Myocardial Infarction 04/30/1984 - "Acylated streptokinase--plasminogen complex in patients with acute myocardial infarction." 08/01/1984 - "The fibrinolytic efficacy and systemic effects on coagulation variables of intracoronary administration of an acylated streptokinase-plasminogen complex (BRL 26921) were assessed in 23 patients with an acute transmural myocardial infarction. " 03/01/1985 - "The effects of BRL 26921, an active-site acylated streptokinase-plasminogen complex, on the fibrinolytic and coagulation systems were studied in 13 patients treated for acute myocardial infarction with a short intravenous infusion of 30 mg of the new drug. " 01/01/1987 - "High-dose systemic streptokinase and acylated streptokinase-plasminogen complex (BRL 26921) in acute myocardial infarction: alterations of the fibrinolytic system and clearance of fibrinolytic activity."
2.	Venous Thrombosis (Deep-Vein Thrombosis) 04/01/1987 - "The treatment of venous thrombosis of the upper and lower limbs with "APSAC" (p-anisoylated streptokinase-plasminogen complex)."
3.	Budd-Chiari Syndrome (Budd Chiari Syndrome) 09/01/1985 - "Budd-Chiari syndrome treated with acylated streptokinase-plasminogen complex."
4.	Hemorrhage 02/01/1986 - "Impressive reopening rates have been reported with acylated streptokinase-plasminogen complex, but unfortunately, its use was associated with extensive systemic fibrinolytic activation and bleeding complications. "

Related Drugs and Biologics

1.	Anistreplase (APSAC)
2.	Streptokinase

Related Therapies and Procedures

1.	Intravenous Infusions